Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Gupta

Showing results (281-290 of 314) with videos related to

Pageof 32
Sort By:
Journal for Immunotherapy of Cancer|March 3, 2021
<i>LRP1B</i> mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer typesLandon C Brown, Matthew D Tucker, Ramy Sedhom, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 13, 2019
Taxane-based Induction Chemotherapy Plus Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma: Prospective Results from a Non-endemic CohortS Ghosh-Laskar, A Pilar, K Prabhash, et al.
BJU International|November 13, 2013
The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panelBerrend G Muller, Jurgen J Fütterer, Rajan T Gupta, et al.
Journal of the American College of Radiology : JACR|November 27, 2022
ACR Appropriateness Criteria® Acute Pyelonephritis: 2022 Update, Andrew D Smith, Paul Nikolaidis, et al.
Journal for Immunotherapy of Cancer|March 22, 2024
Molecular assessment of intratumoral immune cell subsets and potential mechanisms of resistance to odronextamab, a CD20×CD3 bispecific antibody, in patients with relapsed/refractory B-cell non-Hodgkin lymphomaJurriaan Brouwer-Visser, Nathalie Fiaschi, Raquel P Deering, et al.
Prostate Cancer and Prostatic Diseases|March 11, 2022
A randomized controlled trial comparing changes in fitness with or without supervised exercise in patients initiated on enzalutamide and androgen deprivation therapy for non-metastatic castration-sensitive prostate cancer (EXTEND)Michael R Harrison, Paul G Davis, Michel G Khouri, et al.
European Radiology|March 14, 2026
Prostate MRI quality improvement: a Roadmap from the ESUR Prostate MRI Working GroupAdriano B Dias, Jelle Barentsz, Clare Allen, et al.
Journal of the American College of Radiology : JACR|December 1, 2023
ACR Appropriateness Criteria® Acute Onset Flank Pain-Suspicion of Stone Disease (Urolithiasis), Rajan T Gupta, Kevin Kalisz, et al.
Journal of the American College of Radiology : JACR|May 7, 2021
ACR Appropriateness Criteria® Renal Failure, Jade J Wong-You-Cheong, Paul Nikolaidis, et al.
Journal of the American College of Radiology : JACR|November 6, 2019
ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Cancer, Andrei S Purysko, Paul Nikolaidis, et al.
Pageof 32

Showing results (281-290 of 314) with videos related to

Sort By:
Pageof 32
Journal for Immunotherapy of Cancer|March 3, 2021
<i>LRP1B</i> mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer typesLandon C Brown, Matthew D Tucker, Ramy Sedhom, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 13, 2019
Taxane-based Induction Chemotherapy Plus Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma: Prospective Results from a Non-endemic CohortS Ghosh-Laskar, A Pilar, K Prabhash, et al.
BJU International|November 13, 2013
The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panelBerrend G Muller, Jurgen J Fütterer, Rajan T Gupta, et al.
Journal of the American College of Radiology : JACR|November 27, 2022
ACR Appropriateness Criteria® Acute Pyelonephritis: 2022 Update, Andrew D Smith, Paul Nikolaidis, et al.
Journal for Immunotherapy of Cancer|March 22, 2024
Molecular assessment of intratumoral immune cell subsets and potential mechanisms of resistance to odronextamab, a CD20×CD3 bispecific antibody, in patients with relapsed/refractory B-cell non-Hodgkin lymphomaJurriaan Brouwer-Visser, Nathalie Fiaschi, Raquel P Deering, et al.
Prostate Cancer and Prostatic Diseases|March 11, 2022
A randomized controlled trial comparing changes in fitness with or without supervised exercise in patients initiated on enzalutamide and androgen deprivation therapy for non-metastatic castration-sensitive prostate cancer (EXTEND)Michael R Harrison, Paul G Davis, Michel G Khouri, et al.
European Radiology|March 14, 2026
Prostate MRI quality improvement: a Roadmap from the ESUR Prostate MRI Working GroupAdriano B Dias, Jelle Barentsz, Clare Allen, et al.
Journal of the American College of Radiology : JACR|December 1, 2023
ACR Appropriateness Criteria® Acute Onset Flank Pain-Suspicion of Stone Disease (Urolithiasis), Rajan T Gupta, Kevin Kalisz, et al.
Journal of the American College of Radiology : JACR|May 7, 2021
ACR Appropriateness Criteria® Renal Failure, Jade J Wong-You-Cheong, Paul Nikolaidis, et al.
Journal of the American College of Radiology : JACR|November 6, 2019
ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Cancer, Andrei S Purysko, Paul Nikolaidis, et al.
Pageof 32